JANUET 50/850 MG TABLETS

Kraj: Izrael

Język: angielski

Źródło: Ministry of Health

Składnik aktywny:

METFORMIN HYDROCHLORIDE 850 MG; SITAGLIPTIN AS MONOHYDRATE PHOSPHATE 50 MG

Dostępny od:

MERCK SHARP & DOHME ISRAEL LTD

Kod ATC:

A10BA02

Forma farmaceutyczna:

TABLETS

Droga podania:

PER OS

Wyprodukowano przez:

MERCK SHARP & DOHME CORP., USA

Grupa terapeutyczna:

METFORMIN

Wskazania:

Januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. Important limitations of use:Januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.Januet has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Januet.

Data autoryzacji:

2009-01-01